IL3RA and leukemia: As shown in Fig. 5A, mice showing leukaemia engraftment were treated on Day 0 and Day 7 with 5 × 106/mouse effector cells (NT-T, CAR.CD123-T, NT-NK or CAR.CD123-NK cells).